Nevro's high-frequency neurostimulation cuts diabetic neuropathy pain by 80% in 2-year study Globus aims to add Nevro’s portfolio—with its spinal cord ... specialist NuVasive, with the goal ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...

Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp. NVRO in an all-cash transaction valued at approximately $250 million. Under the terms of the agreement, unanimously ...

A Florida federal judge has issued a report and recommended that a sales representative pay more than $19 million to resolve ...